SARNP

SAP domain-containing ribonucleoprotein · P82979 · SARNP on Sugi Atlas →

0 patent compounds predicted against SARNP, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SARNP by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination PHASE1/PHASE2COMPLETED
Effect of PAE Hydrogel Loaded With tRF-ASO-Exo on Patients With Diabetic Ocular Surface Diseases PHASE2NOT_YET_RECRUITING
Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. PHASE1/PHASE2RECRUITING
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Inhibition of SENP1 for the Suppression of OS Growth and Metastasis nanUNKNOWN
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Study of Specimens From Young Patients With Neuroblastoma nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Clinical Study of Spinal Muscular Atrophy nanCOMPLETED
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study nanUNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Genetic Investigation of Cancer Predisposition nanNOT_YET_RECRUITING
Progression Follow up of the First-degree Relatives of Patients With REM Sleep Behavior Disorder nanUNKNOWN
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Apelin12 in Acne Vulgaris nanUNKNOWN
Identification of New FTLD Genes nanUNKNOWN
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SARNP binder may also engage these)

ProteinNameSimilarity
Q5R4V4 1.000 Q5R4V4 →
Q9D1J3 1.000 Q9D1J3 →
Q498U4 1.000 Q498U4 →
EIF3J Eukaryotic translation initiation factor 3 subunit J 0.949 landscape →
Q66JS6 0.945 Q66JS6 →
SAP30BP SAP30-binding protein 0.945 landscape →
Q5ZJ85 0.945 Q5ZJ85 →
Q5R8D1 0.944 Q5R8D1 →
Q5ZKA4 0.943 Q5ZKA4 →
PRPF3 U4/U6 small nuclear ribonucleoprotein Prp3 0.943 landscape →
Q922U1 0.943 Q922U1 →
A0JPM9 0.943 A0JPM9 →
Q0VCU8 0.943 Q0VCU8 →
Q7TNE3 0.943 Q7TNE3 →
Q5R5F1 0.941 Q5R5F1 →
P29540 0.940 P29540 →
Q3UGC7 0.940 Q3UGC7 →
B2GV05 0.940 B2GV05 →
Q8IXM2 0.940 Q8IXM2 →
Q6P320 0.939 Q6P320 →
O75391 0.939 O75391 →
Q5RAD5 0.939 Q5RAD5 →
SF3A1 Splicing factor 3A subunit 1 0.939 landscape →
Q2KIA6 0.938 Q2KIA6 →
Q32LD1 0.938 Q32LD1 →
Q9BY12 0.938 Q9BY12 →
A2VDN6 0.938 A2VDN6 →
Q9Y3C0 0.938 Q9Y3C0 →
Q1RMU5 0.938 Q1RMU5 →
Q96MW1 0.937 Q96MW1 →